Introduction: This prospective, randomized study was designed to measure the effect of nutritional supplementation on serum prealbumin (transthyretin) in pediatric burn patients in seven burn centers in Russia. The primary measure was change in serum prealbumin from baseline to Day 7.
INTRODUCTION
Each year more than 300,000 people die from fire-related burn injuries worldwide [1] . Millions more suffer from burnrelated disabilities and disfigurements with psychological, social and economic effects on both the survivors and their families. The burden of burn injury is one that falls predominately on the world's poor with 95% of fire-related deaths and thermogenesis, and a relaxation of the smooth muscle in the gastrointestinal tract [3] . Once a burn wound exceeds 15-20% of the body surface area, a large number of systemic changes occur such as a major metabolic stress response, impaired immunity and massive fluid shifts [4] , with the hypermetabolic response lasting for 9-12 months following the injury. Children are more vulnerable than adults to burn injuries because of their limited energy reserves, thinner dermis, greater body surface area, and the body's dramatic shift from growth to cellular survival [3] .
One of the greatest threats to survival for burn patients is infection, and because of the relationship among nutrition, immunity and wound healing, optimal nutritional support is extremely important to these patients [4] . The provision of nutrition serves two basic functions: to provide substrate for energy production through intermediary metabolism and to provide necessary nutrients that cannot be synthesized by routine means [5] . Assessment of a burned patient's nutritional status is important but difficult due to underlying problems that can confuse the interpretation of this status, such as impaired immunity from surgery and infection; effect of wound losses and transfusions on serum proteins; changes in the rate of muscle protein breakdown; and rapid physical changes in extracellular volume that can decrease body weight [3] . Body weight is the easiest indicator of a patient's nutritional state, and the preferred biochemical marker for protein malnutrition is prealbumin [3] . Prealbumin is considered the most sensitive indicator of nutritional status because of its rapid turnover and small total body pool, which gives a snapshot of a person's diet at a specific timepoint [6] . C-reactive protein (CRP) is a blood protein that responds to burn injury differently as a marker of inflammation during the early acute phase of burn recovery [7] . Both CRP and prealbumin have been used as prognostic indicators for identifying mortality and infection risk in patients with burn injuries [6] .
This study was designed to test the effect of supplementation with a pediatric formula containing 1.5 kcal/mL, in combination with a prescribed hospital diet, on outcomes for pediatric burn patients as they recovered in a hospital facility.
MATERIALS AND METHODOLOGY

Subjects
This was a randomized, controlled, dual-treatment, parallel study conducted at seven pediatric burn centers in Russia. One hundred sixteen subjects were screened from February 2010 to July 2011, and 54 of these subjects met eligibility criteria. Baseline characteristics of enrolled subjects can be found in Table 1 . Enrollment was complete when the estimated sample size was met for the study. The eligibility criteria for baseline serum prealbumin less than 10 mg/dL disqualified 62 of the screened subjects who had baseline val- ues missing or greater than or equal to 10 mg/dL (28 subjects in the control group and 26 subjects in the experimental group). Because of the relatively mild to moderate burn injuries for the patients, many of the patients were presenting at hospital admission with serum prealbumin levels in normal range (11-20 mg/dL), so the eligibility criteria was changed to only include those patients at nutritional risk, at prealbumin levels < 10 mg/dL since prealbumin was the primary outcome of the study. One subject received the wrong treatment according to the randomization schedule and their data was analyzed according to actual treatment received. The 54 intent-to-treat subjects (23 male and 31 female) had a mean age (± SEM) of 2.70 ± 0.25 years and mean weight (± SEM) of 14.42 ± 0.67 kg. The mean percentages (± SEM) of burn injury for these subjects were the following: mean percentage of TBSA burned at 19.56 ± 0.87; mean percentage of 1 st degree burn at 0.20 ± 0.12; percentage of 2 nd degree burn at 10.35 ± 1.10; percentage of 3 rd degree burn at 7.81 ± 0.88; percentage of 4 th degree burn at 1.19 ± 0.26; and no subjects with 5 th degree burn. All subjects were patients admitted to the hospital within 24 h of burn injury, capable of oral feeding within 72 h of hospitalization, and had at least 15% total body surface area (TBSA) burned with some burn depth at least 2 nd degree and no more than 5% of TBSA at 4 th degree or higher. These subjects were between 1 and 10 y of age, had a baseline serum prealbumin concentration less than 10 mg/dL, and were expected to be hospitalized for at least 14 days. The subjects did not have a history of diabetes or stress-induced hyperglycemia, did not require ventilation or dialysis treatment, did not require parenteral feeding, were not acutely impacted or constipated, and were not taking a chronic pharmaceutical agent that affects metabolism. There were no baseline differences between the two treatment groups for gender, age, body weight, degrees of burn or percentage of TBSA burned. The study protocol was reviewed and approved by an Independent Ethics Committee, Universimed, as well as local ethics committees in Russia, and parents or legal guardians of all enrolled subjects provided informed consent before study participation. The trial was conducted in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki.
Study Procedures
Study personnel at the burn centers screened potential study subjects, obtained informed consent, determined subject eligibility, and enrolled willing and eligible patients. As subjects were enrolled, they were randomized to one of two treatments via sealed, opaque envelopes containing computerized randomization sequences that were generated by the sponsor, separate from clinical study involvement. The randomization envelopes were stored in a secure location at each site. Each site had its own randomization schedule, and randomization was stratified by age (1-4 y age and 5-10 y age) and was fixed with a block size of 2. As eligible subjects were enrolled, they were to be sequentially assigned a subject number in ascending numerical order starting with the first envelope in their appropriate age strata. The two study treatments were the typical hospital diet prescribed to pediatric burn patients as a control and the typical hospital diet plus additional liquid supplementation for oral consumption as the experimental arm. The oral supplement was designed to be consumed in addition to the hypercaloric, highprotein prescribed hospital diet. Due to the nature of the two treatments, it was impossible to implement blinding during the study, but because the primary outcome of the study was objective (serum prealbumin levels), this was not considered an issue. The liquid supplementation was vanilla in flavor and packaged in 200 mL plastic bottles. Each bottle contained 299 kilocalories, 8.40 grams protein, 14.94 grams fat, 32.78 grams carbohydrate, and 1.50 grams fiber (PediaSure Plus Fiber Vanilla; manufactured by Abbott Nutrition, Zwolle, Netherlands). Children ages 1-4 y in the supplementation group were to consume 1 bottle per day, and children 5-10 y were to receive 2 bottles per day during the study period. At baseline, measurements for body weight, serum prealbumin and serum CRP were obtained. After these initial measures, if a subject was in the treatment group, he or she would begin oral supplementation. For the subjects in the treatment group, the mean percent of study product consumed at Days 7 and 14 were 97.90 ± 2.71 and 100.05 ± 0.43 respectively. The hospital personnel administered and documented the intake of the study formula. Body weight, serum prealbumin and serum CRP were measured again at Day 7 and Day 14 in this fourteen-day study. The primary outcome to be measured in the study was the change in serum prealbumin from baseline to Day 7. The original primary outcome for the study was the change in serum prealbumin from baseline to Day 14; however, an interim evaluation of the data revealed a normalization of prealbumin values between Days 7 and 14 of the study because of the mild to moderate burn injuries of the patients. Secondary outcomes were change in serum prealbumin from baseline to Day 14, change in serum CRP from baseline to Day 7 and Day 14, change in body weight during the study, and the number of wound infections during the study. All serum samples were analyzed by IN-VITRO Independent Laboratory (Moscow, Russia) with immunoturbidimetric methodology (Architect ci8200).
Statistics
There were two interim evaluations of the data performed during the study, one was unplanned and the other was planned. Because the study was unblinded, the data was reviewed to determine the suitability of subject eligibility criteria and study outcomes. Based on the summary statistics of interim evaluation data, a study sample size of 50 subjects with non-missing values for the primary variable was determined. A total sample size of 50 (25 per treatment group) would have 80% power to detect a difference in means of 3.64 mg/dL (for serum prealbumin) assuming the common standard deviation is 4.43 mg/dL using a two group t-test with a 0.05 two-sided significance level (nQuery Advisor ® 5.0). The continuous variables were analyzed using analysis of variance (and covariance), repeated measures analysis of covariance, and Wilcoxon's rank sum test. The categorical variables were analyzed using Cochran-Mantel-Haenszel test and Fisher's exact test. Hypothesis tests for treatment effects and interaction were conducted using two-sided, 0.05 and 0.10 level tests respectively. Statistical software SAS release 9.1.3 (SAS Institute Inc, Cary, NC) was used for the analyses.
RESULTS
There were 26 subjects in the supplementation group and 28 subjects in the hospital diet (control) group. No significant differences were observed between the two groups for baseline serum prealbumin concentrations, with mean ± SEM values of 7.84 ± 0.26 mg/dL and 7.60 ± 0.33 mg/dL for the control and experimental groups respectively. All blood data is presented in Table 2 , along with the calculated changes in prealbumin and CRP from baseline over the study period. The difference between treatments for the primary outcome, change in serum prealbumin from baseline to Day 7, is presented in Fig. (1) . The difference was statistically significant (p=0.0265) and the mean changes were 8.44 ± 1.13 mg/dL for the experimental group and 5.47 ± 0.80 mg/dL for the control group, with a difference between the two groups of 2.97 mg/dL over the initial 7 day period. There were no significant differences between the two treatments for change in serum prealbumin from baseline to Day 14, for change in serum CRP from baseline to Day 7 or baseline to Day 14, change in body weight during the study, or number of wound infections. While there appear to be differences between the treatment groups for baseline CRP and change from baseline CRP values, the differences were not statistically significant. Although not statistically significant, there was a mean decrease in body weight from baseline through Day 14 for the hospital diet group, and a mean increase in body weight for the experimental group. Supplementation resulted in a mean increase in body weight of 148 Values are mean ± SEM * denotes a significant difference between treatments, p = 0.0265 Fig. (1) . Comparison of two treatments for change in serum prealbumin from baseline to Day 7 (least squares mean ± SEM values were 5.47 ± 0.80 mg/dL for the hospital diet and 8.44 ± 1.13 mg/dL for hospital diet with supplementation). g at Day 7 and 179 g at Day 14 compared with a mean decrease of 57 g at Day 7 and 56 g at Day 14 in the hospital diet group. There was only one subject having a wound infection during the study, which was in the hospital diet group. There were no statistically significant differences between the two groups for recorded adverse events or serious adverse events during the study. Most adverse events were considered unrelated to study product, and no concerns were noted for safety of the study product.
DISCUSSION
The current recommendation for the treatment of burn injuries is early enteral nutrition (EN). The American Burn Association advocates EN as soon as practical [8] . The Canadian Clinical Practice Guidelines recommend starting EN within 24 to 48 hours after admission to the intensive care unit in critically ill patients [9] . Early enteral nutritional support in severe burns has demonstrated numerous advantages, such as increased caloric intake, insulin secretion and protein retention, improved bowel mucosal integrity, and decreased incidence of stress gastritis [10] .
Because the registration of the commercial study product in Russia required that the nutritional supplement be used and consumed in the clinical study as marketed -as an oral feed, the subjects did not have severe burns. As a result, the subjects had mild to moderate burn injuries, and the effects of supplementation on outcomes in children with more severe burns are unknown, a limitation to the results herein. Another limitation with regards to the severity of burns is the lack of difference between the two treatments for Day 14 prealbumin levels. If study subjects had more moderate to severe burns, greater or more prolonged differences in prealbumin levels may have been observed. With regards to early EN via oral supplementation, the study protocol required that subjects be hospitalized within 24 hours of burn injury and were able to orally feed within 72 hours of hospitalization. All but six subjects (11% of the total sample) started EN within 24-48 hours of burn injury. These six subjects were admitted to regional clinics with burn injury and then transferred to a centralized burn center, and began EN within 72 hours of admittance to regional clinic. As a result, this study was a good example of the positive effects that can be attributed to early enteral nutrition via oral feeding in pediatric burn patients.
Because of the close relationship mentioned previously between nutritional status, often measured by serum prealbumin, and the risk of mortality or infection in burn patients, a positive change in this status is noteworthy, especially in the initial 7-10 days of recovery. While the amount of calories provided to study subjects in the treatment group on a daily basis was not large in quantity (299 kcal/day for 24 patients and 598 kcal/day for 2 older patients), a clinical and statistical difference was observed with this supplementation. This supplementation was in addition to a typical hospital diet that was designed for the recovery of a burn patient. This prescribed hospital diet differed greatly in amounts of energy and protein provided, among the seven Russian hospitals used in the study. Unfortunately, because there were no dietitians or support staff in the Russian burn hospitals that were able to assist with the collection for the nutritional intakes of study subjects, the amount of hospital diet consumed is unknown for both groups. According to current ASPEN Clinical Guidelines, the quantities of protein recommended for critically ill neonates and children are based on limited data, but certain severely stressed states such as significant burn injury may require additional protein supplementation to meet metabolic demands [11] . One commonly used formula for the nutritional management of pediatric burn patients, the Curreri junior formula, calculates the caloric requirements of children age 1-3 years as basal metabolic rate (BMR) + 25 kilocalories/% of burn and for children age 4-15 years as BMR + 40 kilocalories/% of burn [12] .
CONCLUSION
While the amount of energy and protein consumed via hospital diet is unknown for the two treatment groups, the additional nutritional supplementation appears to have a positive effect on recovery from mild to moderate burn injury, whether this is due to a replacement of the hospital diet with the supplementation or because of additional nutrition in combination with the hospital diet. This study shows evidence for an enhanced solution to providing nutritional support to patients in a compromised metabolic state.
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